Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & Prof Simone Strasser
Abnormal LFTs – Practical Cases Expert Q&A
Prof Andrew Sindone AM
MRAs for Heart Failure Update - New Developments
Prof David Price
COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White
Angela Newbound
Practical Strategies to Increase Vaccination Rates This Flu Season
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
